We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about the long-term effects some people can have after having COVID-19.
How to use a cost benefit analysis to evaluate your digital health product.
How to use an interrupted time series to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
Advises on how planning can manage potential noise impacts in new development.
How to use a cost effectiveness analysis to evaluate your digital health product.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
How to use a before-and-after study to evaluate your digital health product.
Information relating to rare side effects after vaccination.
How to use a cost consequence analysis to evaluate your digital health product.
Information on acetone (also known as propanone) for use in responding to chemical incidents.
Information on methyl ethyl ketone (MEK) (also known as 2-butanone) for use in responding to chemical incidents.
Ultrasound has been used in medical practice throughout the world for at least 50 years.
The most recent scientific research on exposure to electric and magnetic fields.
The review of the safety of isotretinoin has concluded.
COMEAP statement on the evidence for differential health effects of particulate matter according to source or components.
Information on bromine, for responding to chemical incidents.
Information on how to report a serious undesirable effect (SUE) or safeguarding issue for cosmetic products.
How to use a crossover randomised controlled trial to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.